Hui Peng1, Huan Ning1, Qinghong Wang1, Wenbao Lu1, Yingzi Chang2, Tony T Wang3, Jinping Lai4, Pappachan E Kolattukudy5, Rong Hou1, Daniel F Hoft1, Mark S Dykewicz1, Jianguo Liu6. 1. Division of Infectious Diseases, Allergy and Immunology, Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, Mo. 2. Pharmacology Department, A.T. Still University, Kirksville, Mo. 3. SRI International, Harrisonburg, Va. 4. Department of Pathology, Saint Louis University School of Medicine, Saint Louis University School of Medicine, St Louis, Mo. 5. Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Fla. 6. Division of Infectious Diseases, Allergy and Immunology, Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, Mo. Electronic address: jianguo.liu@health.slu.edu.
Abstract
BACKGROUND: Asthmatic and allergic inflammation is mediated by TH2 cytokines (IL-4, IL-5, and IL-13). Although we have learned much about how TH2 cells are differentiated, the TH2 checkpoint mechanisms remain elusive. OBJECTIVES: In this study we investigate how monocyte chemotactic protein-induced protein 1 (MCPIP1; encoded by the Zc3h12a gene) regulates IL-5-producing TH2 cell differentiation and TH2-mediated inflammation. METHODS: The functions of Zc3h12a-/- CD4 T cells were evaluated by checking the expression of TH2 cytokines and transcription factors in vivo and in vitro. Allergic airway inflammation of Zc3h12a-/- mice was examined with murine asthma models. In addition, antigen-specific CD4 T cells deficient in MCPIP1 were transferred to wild-type recipient mice, challenged with ovalbumin (OVA) or house dust mite (HDM), and accessed for TH2 inflammation. RESULTS: Zc3h12a-/- mice have spontaneous severe lung inflammation, with an increase in mainly IL-5- and IL-13-producing but not IL-4-producing TH2 cells in the lung. Mechanistically, differentiation of IL-5-producing Zc3h12a-/- TH2 cells is mediated through Notch signaling and Gata3 independent of IL-4. Gata3 mRNA is stabilized in Zc3h12a-/- TH2 cells. MCPIP1 promotes Gata3 mRNA decay through the RNase domain. Furthermore, deletion of MCPIP1 in OVA- or HDM-specific T cells leads to significantly increased TH2-mediated airway inflammation in OVA or HDM murine models of asthma. CONCLUSIONS: Our study reveals that MCPIP1 regulates the development and function of IL-5-producing TH2 cells through the Notch/Gata3 pathway. MCPIP1 represents a new and promising target for the treatment of asthma and other TH2-mediated diseases.
BACKGROUND: Asthmatic and allergic inflammation is mediated by TH2 cytokines (IL-4, IL-5, and IL-13). Although we have learned much about how TH2 cells are differentiated, the TH2 checkpoint mechanisms remain elusive. OBJECTIVES: In this study we investigate how monocyte chemotactic protein-induced protein 1 (MCPIP1; encoded by the Zc3h12a gene) regulates IL-5-producing TH2 cell differentiation and TH2-mediated inflammation. METHODS: The functions of Zc3h12a-/- CD4 T cells were evaluated by checking the expression of TH2 cytokines and transcription factors in vivo and in vitro. Allergic airway inflammation of Zc3h12a-/- mice was examined with murineasthma models. In addition, antigen-specific CD4 T cells deficient in MCPIP1 were transferred to wild-type recipient mice, challenged with ovalbumin (OVA) or house dust mite (HDM), and accessed for TH2inflammation. RESULTS:Zc3h12a-/- mice have spontaneous severe lung inflammation, with an increase in mainly IL-5- and IL-13-producing but not IL-4-producing TH2 cells in the lung. Mechanistically, differentiation of IL-5-producing Zc3h12a-/- TH2 cells is mediated through Notch signaling and Gata3 independent of IL-4. Gata3 mRNA is stabilized in Zc3h12a-/- TH2 cells. MCPIP1 promotes Gata3 mRNA decay through the RNase domain. Furthermore, deletion of MCPIP1 in OVA- or HDM-specific T cells leads to significantly increased TH2-mediated airway inflammation in OVA or HDM murine models of asthma. CONCLUSIONS: Our study reveals that MCPIP1 regulates the development and function of IL-5-producing TH2 cells through the Notch/Gata3 pathway. MCPIP1 represents a new and promising target for the treatment of asthma and other TH2-mediated diseases.
Authors: G J McKenzie; C L Emson; S E Bell; S Anderson; P Fallon; G Zurawski; R Murray; R Grencis; A N McKenzie Journal: Immunity Date: 1998-09 Impact factor: 31.745
Authors: F D Finkelman; I M Katona; J F Urban; J Holmes; J Ohara; A S Tung; J V Sample; W E Paul Journal: J Immunol Date: 1988-10-01 Impact factor: 5.422
Authors: Padraic G Fallon; Sarah J Ballantyne; Niamh E Mangan; Jillian L Barlow; Ayan Dasvarma; Duncan R Hewett; Ann McIlgorm; Helen E Jolin; Andrew N J McKenzie Journal: J Exp Med Date: 2006-04-10 Impact factor: 14.307
Authors: Lili Tu; Terry C Fang; David Artis; Olga Shestova; Seth E Pross; Ivan Maillard; Warren S Pear Journal: J Exp Med Date: 2005-10-17 Impact factor: 14.307
Authors: Ewelina Dobosz; Georg Lorenz; Andrea Ribeiro; Vivian Würf; Marta Wadowska; Jerzy Kotlinowski; Christoph Schmaderer; Jan Potempa; Mingui Fu; Joanna Koziel; Maciej Lech Journal: Dis Model Mech Date: 2021-03-18 Impact factor: 5.758